Complexo Hospitalario Universitario de Santiago
Centro de atención
Stanford University School of Medicine
Stanford, Estados UnidosPublicacións en colaboración con investigadores/as de Stanford University School of Medicine (22)
2024
-
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank
Clinical and experimental rheumatology, Vol. 42, Núm. 2, pp. 277-287
2023
-
Patient perspectives on long-term outcomes in rheumatoid arthritis. A qualitative study from the OMERACT patient outcomes in longitudinal studies working group
Seminars in Arthritis and Rheumatism, Vol. 58
-
Survival after Invasive or Conservative Management of Stable Coronary Disease
Circulation, Vol. 147, Núm. 1, pp. 8-19
2022
-
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function
Kidney International, Vol. 101, Núm. 1, pp. 174-184
-
Proceedings of the 26th Annual Virtual Congress of the International Liver Transplantation Society
Transplantation, Vol. 106, Núm. 9, pp. 1738-1744
-
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)
Nature
-
Stroke genetics informs drug discovery and risk prediction across ancestries
Nature, Vol. 611, Núm. 7934, pp. 115-123
2021
-
Effects of dapagliflozin on mortality in patients with chronic kidney disease: A pre-specified analysis from the DAPA-CKD randomized controlled trial
European Heart Journal, Vol. 42, Núm. 13, pp. 1216-1227
-
Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases
The Lancet Rheumatology, Vol. 3, Núm. 10, pp. e707-e714
-
Outcomes Reported in Prospective Long-Term Observational Studies and Registries of Patients With Rheumatoid Arthritis Worldwide: An Outcome Measures in Rheumatology Systematic Review
Arthritis Care and Research, Vol. 73, Núm. 5, pp. 649-657
-
Outcomes of Participants With Diabetes in the ISCHEMIA Trials
Circulation, Vol. 144, Núm. 17, pp. 1380-1395
2020
-
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: Data from the COVID-19 Global Rheumatology Alliance physician-reported registry
Annals of the Rheumatic Diseases, Vol. 79, Núm. 7, pp. 859-866
2019
2018
-
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants
Nature Communications, Vol. 9, Núm. 1
-
Germline variation at 8q24 and prostate cancer risk in men of European ancestry
Nature Communications, Vol. 9, Núm. 1
-
Incidence and prognostic factors related to major adverse cerebrovascular events in patients with complex aortic diseases treated by the chimney technique
Journal of Vascular Surgery, Vol. 67, Núm. 5, pp. 1372-1379
2017
-
Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention
Journal of the American College of Cardiology, Vol. 69, Núm. 2, pp. 176-185
-
Overexpression of the cytokine BAFF and autoimmunity risk
New England Journal of Medicine, Vol. 376, Núm. 17, pp. 1615-1626
2014
-
A meta-analysis of genome-wide association studies identifies novel variants associated with osteoarthritis of the hip
Annals of the Rheumatic Diseases, Vol. 73, Núm. 12, pp. 2130-2136
-
Assessment of osteoarthritis candidate genes in a meta-analysis of nine genome-wide association studies
Arthritis and Rheumatology, Vol. 66, Núm. 4, pp. 940-949